4.5 Review

Progress in direct reprogramming of dopaminergic cell replacement therapy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Genetics & Heredity

Emerging concepts of miRNA therapeutics: from cells to clinic

Caroline Diener et al.

Summary: In this review, the main challenges and strategies for the therapeutic application of miRNAs are discussed, with particular emphasis on approaches that have already been studied clinically.

TRENDS IN GENETICS (2022)

Article Biochemistry & Molecular Biology

Revisiting astrocyte to neuron conversion with lineage tracing in vivo

Lei-Lei Wang et al.

Summary: Recent studies have shown that in vivo cell fate conversions may not actually be converting astrocytes into neurons, but instead utilizing endogenous neurons. Lineage tracing strategies are necessary to accurately track the origin of converted cells, highlighting the importance of applying stringent tracing techniques in studies of cell fate conversions in vivo.
Review Cell Biology

Direct cell reprogramming: approaches, mechanisms and progress

Haofei Wang et al.

Summary: Direct reprogramming converts cells from one lineage into another without going through a pluripotent state, and it is a promising strategy for generating functional cells for therapeutic purposes. Recent advancements include using defined factors for lineage conversion, enhancing reprogrammed cell maturation, and addressing challenges in in vivo direct reprogramming for translational applications.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)

Review Geriatrics & Gerontology

Current Approaches and Molecular Mechanisms for Directly Reprogramming Fibroblasts Into Neurons and Dopamine Neurons

Fabin Han et al.

Summary: Parkinson's disease is mainly caused by degeneration of dopaminergic neurons in the middle brain, and the transplantation of neural stem cells from different sources has shown promising results in improving motor dysfunction. However, ethical concerns and rejection issues with traditional stem cells have led to the exploration of direct reprogramming of somatic fibroblasts into neurons. This approach presents advantages such as generating patient-specific cells and avoiding safety concerns, although low efficiency and potential risks remain as obstacles to its clinical application.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Article Virology

Efficient RNA Virus Targeting via CRISPR/CasRx in Fish

Qing Wang et al.

Summary: The study successfully engineered a highly effective CasRx system for fish virus interference by targeting the red-spotted grouper nervous necrosis virus (RGNNV) with synthetic mRNA coding for CasRx, resulting in significant interference with virus infections both in vitro and in vivo.

JOURNAL OF VIROLOGY (2021)

Article Cell Biology

Methods for in vitro CRISPR/CasRx-Mediated RNA Editing

Yu-Fan Chuang et al.

Summary: Specific changes in the genome have been achieved by the revolutionary gene-editing tool CRISPR/Cas system, with CasRx, a member of the Cas13d family, showing great therapeutic potential in RNA editing. The programmable RNA editing CRISPR/Cas nucleases have made gene editing safer and more precise.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Cell & Tissue Engineering

Pluripotent Stem Cell-Based Cell Therapy- Promise and Challenges

Shinya Yamanaka

CELL STEM CELL (2020)

Article Multidisciplinary Sciences

Reversing a model of Parkinson's disease with in situ converted nigral neurons

Hao Qian et al.

NATURE (2020)

Review Biochemistry & Molecular Biology

How to reprogram human fibroblasts to neurons

Ziran Xu et al.

CELL AND BIOSCIENCE (2020)

Article Biochemistry & Molecular Biology

Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors

Silvana Konermann et al.

Editorial Material Developmental Biology

Towards stem cell based therapies for Parkinson's disease

Malin Parmar

DEVELOPMENT (2018)

Review Biochemistry & Molecular Biology

Determinants of dopaminergic neuron loss in Parkinson's disease

Dalton James Surmeier

FEBS JOURNAL (2018)

Article Biochemical Research Methods

Reprogramming of somatic cells to induced neural stem cells

Ebrahim Shahbazi et al.

METHODS (2018)

Review Clinical Neurology

Medical and Surgical Management of Advanced Parkinson's Disease

Angelo Antonini et al.

MOVEMENT DISORDERS (2018)

Article Cell & Tissue Engineering

miR-34b/c Regulates Wnt1 and Enhances Mesencephalic Dopaminergic Neuron Differentiation

Roberto De Gregorio et al.

STEM CELL REPORTS (2018)

Article Biochemistry & Molecular Biology

Therapeutic Potential of Induced Neural Stem Cells for Parkinson's Disease

Dong-Hee Choi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Biotechnology & Applied Microbiology

Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model

Pia Rivetti di Val Cervo et al.

NATURE BIOTECHNOLOGY (2017)

Review Cell & Tissue Engineering

Understanding Parkinson's Disease through the Use of Cell Reprogramming

Rebecca Playne et al.

STEM CELL REVIEWS AND REPORTS (2017)

Review Cell & Tissue Engineering

Understanding Parkinson's Disease through the Use of Cell Reprogramming

Rebecca Playne et al.

STEM CELL REVIEWS AND REPORTS (2017)

Article Oncology

Chemical conversion of mouse fibroblasts into functional dopaminergic neurons

Yonghui Wang et al.

EXPERIMENTAL CELL RESEARCH (2016)

Review Medicine, General & Internal

Brain repair and reprogramming: the route to clinical translation

S. Grealish et al.

JOURNAL OF INTERNAL MEDICINE (2016)

Review Neurosciences

Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience

Jerome Mertens et al.

NATURE REVIEWS NEUROSCIENCE (2016)

Article Developmental Biology

How to make a midbrain dopaminergic neuron

Ernest Arenas et al.

DEVELOPMENT (2015)

Article Multidisciplinary Sciences

Cell cycle and p53 gate the direct conversion of human fibroblasts to dopaminergic neurons

Houbo Jiang et al.

NATURE COMMUNICATIONS (2015)

Article Multidisciplinary Sciences

Selective Generation of Dopaminergic Precursors from Mouse Fibroblasts by Direct Lineage Conversion

Changhai Tian et al.

SCIENTIFIC REPORTS (2015)

Review Neurosciences

Development of stem cell-based therapy for Parkinson's disease

Fabin Han et al.

TRANSLATIONAL NEURODEGENERATION (2015)

Review Clinical Neurology

Clinical Spectrum of Levodopa-Induced Complications

Camila Catherine Aquino et al.

MOVEMENT DISORDERS (2015)

Article Medicine, Research & Experimental

Remote control of induced dopaminergic neurons in parkinsonian rats

Maria Teresa Dell'Anno et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Multidisciplinary Sciences

Efficient Reprogramming of Mouse Fibroblasts to Neuronal Cells including Dopaminergic Neurons

Seung-ick Oh et al.

SCIENTIFIC WORLD JOURNAL (2014)

Article Cell & Tissue Engineering

Human Fetal Striatum-Derived Neural Stem (NS) Cells Differentiate to Mature Neurons In Vitro and In Vivo

Emanuela Monni et al.

CURRENT STEM CELL RESEARCH & THERAPY (2014)

Article Cell & Tissue Engineering

Functional Integration of Dopaminergic Neurons Directly Converted from Mouse Fibroblasts

Jongpil Kim et al.

CELL STEM CELL (2011)

Article Cell & Tissue Engineering

Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions

Rajesh Ambasudhan et al.

CELL STEM CELL (2011)

Article Multidisciplinary Sciences

Direct generation of functional dopaminergic neurons from mouse and human fibroblasts

Massimiliano Caiazzo et al.

NATURE (2011)

Article Multidisciplinary Sciences

Direct conversion of human fibroblasts to dopaminergic neurons

Ulrich Pfisterer et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Biochemistry & Molecular Biology

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Kazutoshi Takahashi et al.